Ukraine negotiations still murky after Trump's joint Congress address
After a turbulent several days between the U.S. and Ukraine, President Donald Trump gave no clear signs that American aid to Ukraine would be unpaused in ...
Joplin Globe16h
FDA Accepts Supplemental Biologics License Application for Genentech’s Gazyva for the Treatment of Lupus Nephritis
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...